Close Menu

NEW YORK – Warsaw, Poland-based technology hub Scope Fluidics hopes to make a mark in the point-of-care molecular diagnostics market by providing the industry's fastest highly multiplexed sample-to-answer PCR-based system.

Through its wholly owned subsidiary, Curiosity Diagnostics, its PCR ONE system boasts detection of up to 20 targets from raw sample with a total turnaround time of 15 minutes, and an initial menu including multiplexed tests for methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.
Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.

Jul
23

This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.